William Chow

Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis

Richard T. Silver, William Chow, Attilio Orazi et al. · Blood · 2013 · 114 citations

Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade

William Chow, Clarissa Amaya, Steven Rains et al. · JAMA Dermatology · 2015 · 92 citations

Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma

Clarissa Amaya, Mariah Perkins, Andres Belmont et al. · Oncoscience · 2018 · 48 citations · Full text

Results of a Sarcoma Alliance for Research through Collaboration (SARC) phase II trial of dasatinib in previously treated, high-grade, advanced sarcoma.

Scott M. Schuetze, K. Wathen, Edwin Choy et al. · Journal of Clinical Oncology · 2010 · 36 citations

Decrease in JAK2V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera

Emil Kuriakose, Katherine Vandris, Y. Lynn Wang et al. · Haematologica · 2011 · 35 citations · Full text